Received: 14 December 2020
Accepted: 6 May 2021
First Online: 28 May 2021
: The study was approved by the Institutional Review Boards of Vanderbilt University, Yale University, Pennsylvania State University, and Kaiser Permanente, and written informed consent was obtained from participants.
: Not applicable.
: Dr. Siew has consulted for Akebia, Inc., received honorarium as an invited speaker for the DaVita Annual Physician Conference in 2019, royalties as an author for UptoDate, and serves on the editorial board for CJASN. Dr. Ikizler has consulted for Abbott Renal Care, Fresenius Kabi, Reata and serves as on the editorial board for Kidney International, for which he receives financial compensation. Dr. Ghahramani reported grants from NIH during the conduct of the study. Dr. Go reported grants from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) during the conduct of the study. Dr. Kaufman reported personal fees from NIDDK during the conduct of the study; grant support from Department of Veterans Affairs, Cooperative Studies Program outside the submitted work. Dr. Parikh reported membership on the advisory board of RenalytixAI and owns equity in the same. He also serves as consultant for Genfit and TriCeda.All other authors - no disclosures to report.